Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Im Cannabis Corp (IMCC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: IMCC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.22
1 Year Target Price $8.22
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 25.95% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 10.28M USD | Price to earnings Ratio - | 1Y Target Price 8.22 |
Price to earnings Ratio - | 1Y Target Price 8.22 | ||
Volume (30-day avg) 1 | Beta 2.15 | 52 Weeks Range 1.29 - 7.12 | Updated Date 09/17/2025 |
52 Weeks Range 1.29 - 7.12 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.49 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.75% | Operating Margin (TTM) -2.76% |
Management Effectiveness
Return on Assets (TTM) -7.17% | Return on Equity (TTM) -48.5% |
Valuation
Trailing PE - | Forward PE 16.31 | Enterprise Value 21017064 | Price to Sales(TTM) 0.2 |
Enterprise Value 21017064 | Price to Sales(TTM) 0.2 | ||
Enterprise Value to Revenue 0.56 | Enterprise Value to EBITDA 7.36 | Shares Outstanding 5246810 | Shares Floating 2405895 |
Shares Outstanding 5246810 | Shares Floating 2405895 | ||
Percent Insiders 44.66 | Percent Institutions 4.31 |
Upturn AI SWOT
Im Cannabis Corp
Company Overview
History and Background
IM Cannabis Corp. was founded with the aim of becoming a leading international cannabis company. It has grown through strategic acquisitions and partnerships, focusing on medical and recreational cannabis markets.
Core Business Areas
- Medical Cannabis: Cultivation, processing, and distribution of medical cannabis products to patients and healthcare providers.
- Recreational Cannabis: Production and sale of recreational cannabis products through various channels.
- Distribution & Retail: Operating retail dispensaries and distribution networks for cannabis products.
- Cultivation: Cultivating Cannabis in various farms.
Leadership and Structure
Information about Im Cannabis Corp's leadership team and organizational structure is not readily available through basic searches.
Top Products and Market Share
Key Offerings
- Dried Flower: Various strains of dried cannabis flower for smoking or vaporization. Market share data not readily available. Competitors include Canopy Growth, Aurora Cannabis, and Tilray Brands.
- Cannabis Oils: Cannabis-infused oils for oral consumption or topical application. Market share data not readily available. Competitors include Cronos Group and Organigram.
- Edibles: Cannabis-infused edibles such as gummies and chocolates. Market share data not readily available. Competitors include Wana Brands (acquired by Canopy Growth).
Market Dynamics
Industry Overview
The cannabis industry is rapidly evolving with increasing legalization and acceptance globally. It is characterized by high growth potential, regulatory complexities, and intense competition.
Positioning
Im Cannabis Corp aims to establish itself as a significant player in the international cannabis market, focusing on both medical and recreational segments. Competitive advantages would ideally include strong branding, efficient operations, and strategic partnerships.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions USD over the next decade. Im Cannabis Corp's TAM depends on its geographic reach and target market segments.
Upturn SWOT Analysis
Strengths
- International presence
- Focus on medical and recreational markets
- Strategic acquisitions and partnerships
- Diverse product portfolio
Weaknesses
- Lack of publicly available detailed financial information.
- Intense competition in the cannabis industry
- Regulatory uncertainties and compliance costs
- Limited brand recognition compared to larger players
Opportunities
- Expansion into new geographic markets
- Development of innovative cannabis products
- Increased legalization and acceptance of cannabis
- Strategic partnerships with established companies
Threats
- Intense competition from established players
- Regulatory changes and compliance costs
- Fluctuations in cannabis prices
- Negative perception of cannabis in some regions
Competitors and Market Share
Key Competitors
- CGC
- TLRY
- ACB
- CRON
Competitive Landscape
Im Cannabis Corp faces intense competition from larger, more established players. Success depends on differentiating its products, building strong brands, and managing costs effectively. The US cannabis industry is very fragmented. These percentages are estimates.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are not readily available through basic searches.
Future Projections: Future growth projections are not readily available through basic searches.
Recent Initiatives: Recent strategic initiatives are not readily available through basic searches.
Summary
IM Cannabis Corp is an international cannabis company navigating a competitive and regulated industry. While it has a focus on both medical and recreational markets, it faces challenges from larger competitors and regulatory uncertainties. Strategic acquisitions and product innovation are key to its future success. Detailed financial data and market share information are difficult to obtain, limiting a full assessment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company websites
- Industry reports
- News articles
- Market research
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Im Cannabis Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-05-20 | Executive Chairman & CEO Mr. Oren Shuster | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees - | Website https://imcannabis.com |
Full time employees - | Website https://imcannabis.com | ||
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.